Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03474965
Brief Title: Study of Dose Confirmation and Safety of Crizanlizumab in Pediatric Sickle Cell Disease Patients

First Submitted : March 16, 2018
First Submitted that Met QC Criteria : March 16, 2018
First Posted : March 23, 2018

Last Update Submitted that Met QC Criteria : October 1, 2021
Last Update Posted : October 7, 2021